Evidence map›Paper›PMID 32403879›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Research progress of prewarning parameters of pre-hepatic failure].

Q Zhang, T Han

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Q ZhangDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin 300170, China; Department of Hepatology, Third Central Hospital of Tianjin Affiliated to Nankai University, Tianjin 300170, China; Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China.
T HanDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin 300170, China; Department of Hepatology, Third Central Hospital of Tianjin Affiliated to Nankai University, Tianjin 300170, China; Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China.
Tianjin Third Central Hospital · CN

Funding

National Natural Science Foundation of China 81870429National Science and Technology Major Program 2017ZX10203201-007
6 · The paper itself

Abstract

Liver failure is a common clinical syndrome of severe liver disease, with high short-term mortality. Although there is currently no standardized and unified diagnostic criteria for pre-hepatic failure in the world, so the proposal of its concept is of great significance to further improve the prewarning of liver failure. This article reviews the prewarning parameters of the risk of liver failure related from the perspectives of etiologies, clinical laboratory tests and pathogenesis, and thereby aims to help clinicians improve their understanding of early diagnosis of liver failure and promote related research to further reduce the mortality rate of patients with liver failure.

Indexed as

Early DiagnosisHepatic InsufficiencyHumansLiver FailureLiver failurePathogenesisPre-stage prewarning

Identifiers

PMID32403879
PMCPMC12770653
OpenAlexW3027572781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.